Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 9, 2000

View Archived Issues

Lion, Paradigm Form Alliance To Develop Informatics Tools

CAT's D2E7 First Fully Human Monoclonal To Reach Phase III

Swiss Show MIF Cytokine Has Potential Role In Septic Shock

Risk Assessment Policy Leaves Decisions To Member States

CeNeS Licenses Pain Product, Gets Investment From Bioglan

Israeli Biotech Seeks Added Government, Private Funding

Transghne Cuts Losses As It Nears New Collaborations

Cantab Shares Fall After Word Of Challenge To DISC Patents

Artemis, Bayer Form Alliance For New Toxicology Methods

Oxford BioMedica Gains On News Of Macrophage Delivery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.